tiprankstipranks
Advertisement
Advertisement
Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain
PremiumCompany AnnouncementsInovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain
2M ago
Inovio reports Q1 EPS (28c), consensus (33c)
Premium
The Fly
Inovio reports Q1 EPS (28c), consensus (33c)
2M ago
Inovio options imply 15.1% move in share price post-earnings
Premium
The Fly
Inovio options imply 15.1% move in share price post-earnings
2M ago
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
PremiumCompany AnnouncementsInovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
3M ago
Inovio files to sell common stock, no amount given
Premium
The Fly
Inovio files to sell common stock, no amount given
3M ago
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
Premium
Market News
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
4M ago
Inovio, Akeso announce clinical collaboration
PremiumThe FlyInovio, Akeso announce clinical collaboration
4M ago
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
Premium
Class Action
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
4M ago
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100